The following important adverse reactions are described below and elsewhere in labeling:
Serotonin Syndrome or NMS-like Reactions [see Warnings and Precautions (5.1)]
Valvular Heart Disease [see Warnings and Precautions (5.2)]
Cognitive Impairment [see Warnings and Precautions (5.3)]
Psychiatric Disorders [see Warnings and Precautions (5.4)]
Hypoglycemia [see Warnings and Precautions (5.5)]
Heart Rate Decreases [see Warnings and Precautions (5.7)]
Hematological Changes [see Warnings and Precautions (5.8)]
Prolactin Elevation